Alan Clement will participate in a panel entitled, “Preparing for the Future: Calling Attention to Biological Products Coming Off-Patent and Devising Forward-Thinking Portfolio Strategies” along with IP Associate General Counsel of Baxter Healthcare Corporation at the 11th ACI Summit on Biosimilars & Innovator Biologics on September 24, 2020 at 2:30 p.m. ET.
To find out more about the panel, click here.
Sign up for our newsletter and get the latest to your inbox.